Cancer-Related Pain Management in Suitable Intrathecal Therapy Candidates: A Spanish Multidisciplinary Expert Consensus
- PMID: 37623011
- PMCID: PMC10453610
- DOI: 10.3390/curroncol30080530
Cancer-Related Pain Management in Suitable Intrathecal Therapy Candidates: A Spanish Multidisciplinary Expert Consensus
Abstract
A consensus is needed among healthcare professionals involved in easing oncological pain in patients who are suitable candidates for intrathecal therapy. A Delphi consultation was conducted, guided by a multidisciplinary scientific committee. The 18-item study questionnaire was designed based on a literature review together with a discussion group. The first-round questionnaire assessed experts' opinion of the current general practice, as well as their recommendation and treatment feasibility in the near future (2-3-year period) using a 9-point Likert scale. Items for which consensus was not achieved were included in a second round. Consensus was defined as ≥75% agreement (1-3 or 7-9). A total of 67 panelists (response rate: 63.2%) and 62 (92.5%) answered the first and second Delphi rounds, respectively. The participants were healthcare professionals from multiple medical disciplines who had an average of 17.6 (7.8) years of professional experience. A consensus was achieved on the recommendations (100%). The actions considered feasible to implement in the short term included effective multidisciplinary coordination, improvement in communication among the parties, and an assessment of patient satisfaction. Efforts should focus on overcoming the barriers identified, eventually leading to the provision of more comprehensive care and consideration of the patient's perspective.
Keywords: Delphi technique; cancer; consensus; intrathecal; pain.
Conflict of interest statement
C.P., T.Q., M.A.C., M.J.G., M.M., and A.I.G. acknowledge receiving grants from Medtronic Ibérica S.A. to conduct this project. T.Q. has received honoraria from Lilly, AstraZeneca, Daichi, Novartis, Roche, Rovi, and MSD outside the submitted work. I.P. has an educational contract with Medtronic Ibérica and Medtronic Europe and declares Medtronic stock ownership. M.A. is employed full-time by Medtronic Ibérica; S.A., M.C., and L.L. are employed full-time by Outcomes’10, a consultancy firm, which has received economic funding from Medtronic Ibérica, S.A. to develop this work. The authors hereby declare that this economic support has not interfered with the development of this project. The authors state that the sponsor did not participate or influence the analysis of the present study or the interpretations of its results. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
References
-
- Porta-Sales J., Nabal-Vicuna M., Vallano A., Espinosa J., Planas-Domingo J., Verger-Fransoy E., Julia-Torras J., Serna J., Pascual-Lopez A., Rodriguez D., et al. Have We Improved Pain Control in Cancer Patients? A Multicenter Study of Ambulatory and Hospitalized Cancer Patients. J. Palliat. Med. 2015;18:923–932. doi: 10.1089/jpm.2015.29002.jps. - DOI - PubMed
-
- WHO . WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents. WHO Guidelines Approved by the Guidelines Review Committee; Geneva, Switzerland: 2018. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
